Company intelligence / Profile preview
Betaliq, Inc.
Tampa, Florida, United Statesbetaliq.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Betaliq has completed Phase 2a trials for BTQ1902 (timolol suspension) with positive results and is advancing toward Phase 3 clinical trials. The company has also initiated enrollment for Phase 2 clinical trials investigating BTQ-1901-A, BTQ-1901-B, and BTQ-1902 for the treatment of glaucoma or ocular hypertension[4][6].
- Therapeutic areas
- Ophthalmology
- Modalities
- Small molecules (beta blockers)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Novaliq GmbHBLP Management Group, LLC
Beyond the preview
Go deeper on Betaliq, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Betaliq, Inc..